Literature DB >> 1279979

Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers.

S E Herrick1, P Sloan, M McGurk, L Freak, C N McCollum, M W Ferguson.   

Abstract

As part of a major clinical trial, sequential biopsies were taken from the margins of venous leg ulcers during their healing. The changing patterns of tissue architecture and extracellular matrix synthesis during healing were documented histologically and immunocytochemically. Initial biopsies were similar in appearance: prominent fibrin cuffs, variable inflammation, hemosiderin, and red blood cell extravasation. So called "fibrin cuffs" were highly organized structures composed of laminin, fibronectin, tenascin, and collagen as well as trapped leukocytes and fibrin. Fibronectin was absent from the ulcer tissue although collagen was abundant. Major histologic changes were observed after 2 weeks' pressure bandage therapy; hemosiderin, acute inflammation, and granulation tissue with the deposition of fibronectin had all increased and epithelial migration had commenced. Complete epithelialization was frequent by the fourth week of treatment, but the basement membrane was incomplete. At this time, hemosiderin and red blood cell extravasation had decreased and "fibrin cuffs" were virtually absent although chronic inflammation remained. The complex organization of the so-called "fibrin cuffs" may inhibit angiogenesis (but offer protection against increased venous pressure) in addition to their previously ascribed role in causing tissue ischemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279979      PMCID: PMC1886678     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

Review 1.  Aetiology of venous ulceration.

Authors:  K G Burnand
Journal:  Br J Surg       Date:  1990-05       Impact factor: 6.939

2.  The cause of venous ulceration.

Authors:  N L Browse; K G Burnand
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

3.  Causes of venous ulceration: a new hypothesis.

Authors:  P D Coleridge Smith; P Thomas; J H Scurr; J A Dormandy
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

4.  Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy.

Authors:  G D Johnson; R S Davidson; K C McNamee; G Russell; D Goodwin; E J Holborow
Journal:  J Immunol Methods       Date:  1982-12-17       Impact factor: 2.303

5.  Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration.

Authors:  K G Burnand; I Whimster; A Naidoo; N L Browse
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-16

6.  Oxpentifylline treatment of venous ulcers of the leg.

Authors:  M P Colgan; J A Dormandy; P W Jones; I G Schraibman; D G Shanik; R A Young
Journal:  BMJ       Date:  1990-04-14

7.  Dermal pericapillary fibrin in venous disease and venous ulceration.

Authors:  V Falanga; H H Moosa; A J Nemeth; S P Alstadt; W H Eaglstein
Journal:  Arch Dermatol       Date:  1987-05

8.  Venous ulceration, fibrinogen and fibrinolysis.

Authors:  R D Leach
Journal:  Ann R Coll Surg Engl       Date:  1984-07       Impact factor: 1.891

9.  Chronic ulceration of the leg: extent of the problem and provision of care.

Authors:  M J Callam; C V Ruckley; D R Harper; J J Dale
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

10.  Intravenous prostaglandin E1 in the treatment of venous ulcers--a double-blind, placebo-controlled trial.

Authors:  G Rudofsky
Journal:  Vasa Suppl       Date:  1989
View more
  34 in total

Review 1.  Management of venous leg ulcers.

Authors:  Deborah A Simon; Francis P Dix; Charles N McCollum
Journal:  BMJ       Date:  2004-06-05

2.  Chronic wounds - is cellular 'reception' at fault? Examining integrins and intracellular signalling.

Authors:  Alan D Widgerow
Journal:  Int Wound J       Date:  2012-04-11       Impact factor: 3.315

3.  No need for biopsies: comparison of three sample techniques for wound microbiota determination.

Authors:  Kristine Gjødsbøl; Mette E Skindersoe; Jens Jørgen Christensen; Tonny Karlsmark; Bo Jørgensen; Anders Mørup Jensen; Bjarke M Klein; Michael K Sonnested; Karen A Krogfelt
Journal:  Int Wound J       Date:  2011-11-09       Impact factor: 3.315

4.  Altered ECM deposition by diabetic foot ulcer-derived fibroblasts implicates fibronectin in chronic wound repair.

Authors:  Anna G Maione; Avi Smith; Olga Kashpur; Vanessa Yanez; Elana Knight; David J Mooney; Aristidis Veves; Marjana Tomic-Canic; Jonathan A Garlick
Journal:  Wound Repair Regen       Date:  2016-06-08       Impact factor: 3.617

Review 5.  The Effect of pH on the Extracellular Matrix and Biofilms.

Authors:  Eleri M Jones; Christine A Cochrane; Steven L Percival
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-07-01       Impact factor: 4.730

6.  Recombinant fibronectin matrix mimetics specify integrin adhesion and extracellular matrix assembly.

Authors:  Daniel C Roy; Denise C Hocking
Journal:  Tissue Eng Part A       Date:  2012-11-01       Impact factor: 3.845

7.  Fibronectin matrix mimetics promote full-thickness wound repair in diabetic mice.

Authors:  Daniel C Roy; Nancie A Mooney; Carol H Raeman; Diane Dalecki; Denise C Hocking
Journal:  Tissue Eng Part A       Date:  2013-08-12       Impact factor: 3.845

Review 8.  Integrin Regulation of Epidermal Functions in Wounds.

Authors:  Whitney M Longmate; C Michael Dipersio
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-03-01       Impact factor: 4.730

9.  Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.

Authors:  Tony J Parker; James A Broadbent; Jacqui A McGovern; Daniel A Broszczak; Christina N Parker; Zee Upton
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

10.  Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB.

Authors:  G F Pierce; J E Tarpley; R M Allman; P S Goode; C M Serdar; B Morris; T A Mustoe; J Vande Berg
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.